Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: took Moderna vaccine and tested positive for Covid-19; This spontaneous case was reported by a patient and describes the occurrence of SARS-COV-2 TEST POSITIVE (took Moderna vaccine and tested positive for Covid-19) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (took Moderna vaccine and tested positive for Covid-19). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) ongoing from 02-Jun-2022 for COVID-19 treatment, at a dose of UNK, qd. At the time of the report, SARS-COV-2 TEST POSITIVE (took Moderna vaccine and tested positive for Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, SARS-CoV-2 test: positive (Positive) Positive.         No concomitant medication information was provided.  Patient received two Moderna COVID 19 vaccines and recently tested positive for COVID-19.  Patient started taking Paxlovid day before reporting date and asked if it was ok to receive Paxlovid even though patient had the Moderna COVID 19 vaccine instead of the Pfizer COVID 19 vaccine. Patient also asked whether she need to take the Paxlovid tablets at the exact same time each day and if there were any serious side effects of Paxlovid. Reporter stated that the writing on the paperwork inside the Paxlovid pill box needs to be larger for seniors to read it. Reporter asked to follow up with doctor for clarification.  Company Comment: This spontaneous case concerns a female patient, of unknown age, with no medical history reported, who experienced the unexpected, non-serious AESI of SARS-CoV-2 test positive. The event occurred on an unspecified date after receiving the second dose of the mRNA-1273 vaccine on an unspecified date. It was reported that the patient received two doses of the mRNA-1273 vaccine (unspecified dates) and had tested positive for COVID-19. No symptoms were reported. At the time of the report, the patient was on day 2 of Paxlovid (nirmatrelvir, ritonavir) treatment. No further details were provided. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a female patient, of unknown age, with no medical history reported, who experienced the unexpected, non-serious AESI of SARS-CoV-2 test positive. The event occurred on an unspecified date after receiving the second dose of the mRNA-1273 vaccine on an unspecified date. It was reported that the patient received two doses of the mRNA-1273 vaccine (unspecified dates) and had tested positive for COVID-19. No symptoms were reported. At the time of the report, the patient was on day 2 of Paxlovid (nirmatrelvir, ritonavir) treatment. No further details were provided. The benefit-risk relationship of the mRNA-1273 vaccine is not affected by this report.